DYADIC INTERNATIONAL INC
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
1044 NORTH U.S. HIGHWAY ONE, JUPITER, FL, 33477
Mailing Address
1044 NORTH U.S. HIGHWAY ONE, JUPITER, FL, 33477
Phone
561-743-8333
Fiscal Year End
1231
EIN
450486747
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 25, 2026 | View on SEC |
| 10-K Annual financial report | March 25, 2026 | View on SEC |
| 8-K Current report of material events | March 6, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 6, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
Annual Reports
10-K
March 25, 2026
- Rebranded as Dyadic Applied BioSolutions to focus on commercial growth and near-term sales.
- Leveraging C1 and Dapibus platforms to provide cost-effective protein production for biotech and food industries.
Material Events
8-K
Financial Distress
March 30, 2026
High Impact
- Innovative C1-cell technology platform for vaccine and drug development
- Active growth phase with potential for new licensing deals and partnerships
8-K
Financial Distress
December 29, 2025
High Impact
- Dyadic International Inc. received a warning notice from Nasdaq because its stock price has been trading below $1 per share for 30 consecutive business days.
- The company faces a significant risk of delisting from Nasdaq if it fails to regain compliance with the minimum bid price rule.
Related Companies
Companies in the same industry (SIC: 2836)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
Relay Therapeutics, Inc.
RLAY
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
COMPUGEN LTD
CGEN
Biological Products, (No Diagnostic Substances)
Protara Therapeutics, Inc.
TARA
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.